- The Myeloma Beacon - https://myelomabeacon.org -
Northern Lights: Starting Treatment With Darzalex
By: Nancy Shamanna; Published: October 12, 2019 @ 3:03 pm | Comments Disabled
As I mentioned in my recent columns, my M-spike and serum free light chain levels have been rising over the past few months, indicating I might have to start treatment in the near future. The reprieve from medications this year had been really nice, but in the world of myeloma, it seems to be wishful thinking that my disease would suddenly halt and disappear without help from the drugs available to us now.
So, earlier this month, upon consultation with my doctors and my family, I decided to try a new drug combination: Darzalex (daratumumab), Revlimid (lenalidomide), and dexamethasone. My doctors are really keen on this treatment given the positive results seen with it so far in clinical trials.
I am currently generally healthy. Apart from the myeloma proteins, my other blood markers are normal, and I am as fit as I have ever been in my sixties. I still walk a lot and spend lots of time with my young grandchildren, so it seems like a good idea to try this new treatment now before I get sicker again.
Once we made the decision to start treatment again, things moved quickly. Before starting Darzalex, my blood counts had to be good, so I had many blood tests as well as a bone marrow aspirate done.
I also had to get blood typing done because Darzalex can mask one’s blood type, and it needs to be known in case transfusions become necessary at some point in the future. As part of the blood typing, I needed to undergo some antibody screening for hepatitis varieties and other blood disorders. These tests turned out well, and I now have a blood bank ID number in case I need any blood transfusions in the future. I used to donate blood before I got cancer, and now know how vital these donations can be for patients.
I was informed that the first Darzalex infusion can cause a number of side effects, such as tiredness, nausea, diarrhea, constipation, vomiting, muscle spasms, joint pain, fever, chills, dizziness, cough, and shortness of breath. This is a long and rather daunting list, and for the first infusion special precautions are taken, including an 8-hour infusion time and the administration of pre-medications to deter some of the potential side effects.
The pre-medications included montelukast (Singulair), an asthma medicine, taken the night before and one hour prior to the infusion in the morning. This drug is only to be taken prior to the first Darzalex infusion. The night before I also took a tablet of Benadryl (diphenhydramine), an antihistamine.
In the morning, one hour prior to the infusion, I also took 20 mg of dexamethasone. I have no choice as to when to take the dex since it is needed to help with the infusion. In addition, I swallowed two tablets of acetaminophen (paracetamol, Tylenol) and another of Benadryl.
As part of the new treatment plan, I am now taking 10 mg of Revlimid and a daily injection of Innohepp (tinzaparin) to prevent clot formation (I have stopped taking low-dose aspirin now). I am still taking anastrozole (Arimidex), my breast cancer maintenance medication. These dosages and drugs may be adjusted as my treatments go along, but that is what I am starting out with.
I was quite nervous about the first infusion because I didn’t exactly know what to expect. The nursing staff in the treatment area was very pleasant and tried to reassure me that everything would be fine. I was settled into a reclining chair and a warm blanket was put over me. A needle was clamped into the back of my right hand and tubing taped to my arm. The tubes ran up onto an IV pole where the bag of Darzalex and bags of saline were hanging.
For the first long infusion, there were 1,100 milliliters (1.1 liters) of fluid in the Darzalex bag. Needless to say, I got quite hydrated during this long day.
For the first two to three hours of the infusion, I did not feel very well. At one point, I thought I was getting a fever. A nurse took my temperature, but all was normal. The infusion ran for 50 ml for the first hour, 100 ml for the second hour, 150 ml for the third hour, and then 200 ml per hour for the next four hours. There were rinses with saline before and after the Darzalex infusion.
It was a long day, but I got up during the infusion, unplugged the IV pole from the wall, and walked around sometimes.
Our daughters came in to visit me, and my husband Dilip sat with me too. I even had a friend visit after they learned that I was receiving treatment. The nurses were helpful and cheerful too. Volunteers came in with their trolley, serving beverages and cookies. When I had some quiet time, I listened to music on my iPod and tried to memorize a poem ("The Night Before Christmas").
I didn’t have any side effects that were serious enough to stop the infusion or give me additional drugs. I was very thankful for that. I felt much better by the afternoon, and I think that the effects of the drugs I had taken in the morning (except for the dex) were wearing off at that point.
We left the cancer center late in the afternoon. I was quite tired and felt washed out, but we walked back to our vehicle and got home. I wasn’t very hungry and went to bed early. I took a sleeping aid to counteract the dex, and also another Benadryl, since my nose was stuffy. I slept fairly well that night, considering all that had happened in the previous two days.
The next couple of days, I was coughing and sneezing quite a bit and took more Benadryl. I also noticed that I was still over hydrated. Since I have taken Revlimid and dex before, I was able to identify the side effects associated with them. I took sleeping pills for three nights, which is more than I would have done in the past. I thought that I might have gastrointestinal problems from the Revlimid, and took some polyethylene glycol (Miralax), but it wasn’t needed. In addition, I am icing the spot where I am getting the daily Innohep injection to prevent bruising. Fortunately, the injections into the abdominal area are not painful.
The Darzalex infusion along with the weekly dex was administered on Wednesday, and by the weekend, I felt more normal again.
All in all, things went better than expected with the first Darzalex infusion. I hope it continues that way with the subsequent infusions.
───────────────── ♦ ─────────────────
The quotation for this month is from C.S. Lewis (1898 - 1963), an Irish-born scholar and novelist, who said: "You are never too old to set another goal or to dream a new dream."
And to all the Beacon's Canadian readers: Happy Thanksgiving!
Nancy Shamanna is a multiple myeloma patient and a columnist at The Myeloma Beacon. You can view a list of her columns here [1].
If you are interested in writing a regular column to be published by The Myeloma Beacon, please contact the Beacon team at .
Article printed from The Myeloma Beacon: https://myelomabeacon.org
URL to article: https://myelomabeacon.org/headline/2019/10/12/northern-lights-starting-treatment-with-darzalex/
URLs in this post:
[1] here: https://myelomabeacon.org/author/nancy-shamanna/
Click here to print.
Copyright © The Beacon Foundation for Health. All rights reserved.